Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
Clinical trial NCT00306566 · COMPLETED
Trial details
- NCT number
- NCT00306566
- Sponsor
- Cytos Biotechnology AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.